Investors

Press Releases

Endonovo Therapeutics Announces Method for Large Scale Expansion of Cord Blood
Endonovo Therapeutics Announces Corporate Patent Licensing Program
Endonovo Therapeutics Targets Non-Invasive Treatment for Acute and Chronic Inflammatory Conditions of the Liver
Endonovo Therapeutics Enters into a $3 Million Equity Purchase Agreement with Kodiak Capital Group, LLC
Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Endonovo Therapeutics to Develop Next Generation, Off-The-Shelf, Cell Free Regenerative Products
Endonovo Therapeutics Affects 1-for-100 Reverse Stock Split
Endonovo Therapeutics Changes Ticker Symbol to ENDV
RSS
Show All